The two most important things you can do to prevent cervical cancer are to get the HPV vaccine if you are eligible, and to be tested regularly according to American Cancer Society (ACS) guidelines.

Finding cervical cancer often starts with an abnormal HPV (human papillomavirus) or Pap test result. This will lead to further tests which can diagnose cervical cancer or pre-cancer. The Pap test and ...

Women aged 25–49 years living in England considered at low risk of cervical cancer following testing will now be invited for screening every 5 years instead of every 3 years. The changes, announced by ...

References 1. DaCosta V, Wynter S, Harriott J, Christie L, Frederick J, and Frederick-Johnston S. Laparoscopic cervicoisthmic cerclage for the treatment of cervical incompetence:case reports. West ...

Minimally invasive surgery (MIS) incorporates surgical instruments through small incisions to perform procedures. Despite the potential advantages of MIS, the lack of tactile sensation and haptic ...

LLETZ stands for large loop excision of the transformation zone. It’s also known as loop electrosurgical excision (LEEP) or loop diathermy. This is the most common treatment for abnormal cervical ...

Patients with cervical cancer who undergo RVT are followed every 3 months for 2 years, then every 6 months for 3 years, and then yearly. Each visit entails a Papanicolaou (Pap) smear and ...

Cervical screening, while not a diagnostic test, is for people without symptoms and aims to detect early changes which could go on to develop into cervical cancer if left untreated.

In the South West, NHS teams are working to increase uptake in the HPV vaccine and cervical screening in line with the national cervical cancer elimination strategy for England. It comes as NHS ...

HPV And Cervical Cancer Risk 99% of all cervical cancer cases are associated with an HPV infection, according to the WHO. HPV is not a single virus but a group of 200 known viruses that not only ...

New research suggests that patients with early-stage cervical cancer and no high-risk factors for recurrence may be able to safely forgo adjuvant therapy, as long as they do not have grade 3 ...

In 2023-24, 5.12 million women in England aged between 25-64 were due a cervical cancer screening, only 3.25 million women were tested – 99.8% of cases are preventable if women regularly attend ...